HHS Terminates Millions in Pediatric Grants Amid Policy Shift; AAP Warns of Risks to Child Health

Spread the Message

Read Time:4 Minute, 42 Second

Wednesday, December 17, 2025

WASHINGTON — In a move that has sent shockwaves through the medical community, the U.S. Department of Health and Human Services (HHS) has abruptly canceled millions of dollars in federal grants previously awarded to the American Academy of Pediatrics (AAP). The decision, announced Wednesday, terminates seven major projects dedicated to critical public health issues, including the reduction of sudden infant death syndrome (SIDS), early autism detection, and the prevention of fetal alcohol spectrum disorders.

The cancellation marks a significant escalation in the ongoing friction between the federal health department and the nation’s largest professional organization of pediatricians. While HHS officials maintain the cuts are part of a broader effort to realign government spending with new departmental priorities, AAP leadership warns that the “sudden withdrawal” of these funds will directly jeopardize the health of infants and children across the United States.

A Shift in Priorities

According to an HHS spokesperson, the grants were sunset because they “no longer align with the Department’s mission or priorities.” This justification follows a year of structural and ideological shifts within the department under Secretary Robert F. Kennedy Jr., who has frequently criticized the AAP for its stances on vaccine policy and public health messaging.

Sources cited by the Washington Post and The Guardian indicate that the termination letters specifically flagged the AAP’s use of “identity-based language”—including references to racial disparities in healthcare and the use of the term “pregnant people”—as being out of step with current CDC and HHS objectives.Jamie Legier, director of the CDC’s office of grants services, reportedly informed the AAP that these elements were “woven through the title, narrative, and work plans” of the projects, making them incompatible with the administration’s framework.

The Impact on Pediatric Care

The AAP, which represents 67,000 pediatricians, confirmed that the seven canceled grants included three from the Centers for Disease Control and Prevention (CDC) and four from the Health Resources and Services Administration (HRSA). The funding supported a wide net of services, including:

Infant Safety: Programs aimed at reducing SIDS and other sleep-related infant deaths.
Neurodevelopmental Health: Efforts to improve early identification of autism and support for children with birth defects.
Rural and Mental Health: Initiatives to expand healthcare access in underserved rural areas and provide adolescent mental health services.
Prevention: Research and outreach regarding fetal alcohol spectrum disorders.

“The sudden withdrawal of these funds will directly impact and potentially harm infants, children, youth, and their families in communities across the United States,” said Mark Del Monte, CEO and executive vice president of the AAP. Del Monte added that the organization is exploring all options, including potential legal recourse, to challenge the decision.

Mounting Tensions Over Vaccine Policy

The funding cuts arrive as the AAP leads a legal challenge against HHS over recent changes to the national vaccine schedule. Earlier this year, Secretary Kennedy announced a downgrade of COVID-19 and Hepatitis B vaccine recommendations for children, moves that the AAP labeled “irresponsible and purposely misleading.”

In June, AAP President Susan J. Kressly stated that the organization would not “lend our name or our expertise to a system that is being politicized at the expense of children’s health.”Secretary Kennedy has countered by questioning the AAP’s independence, suggesting on social media that the group’s recommendations may be influenced by “Big Pharma benefactors”—a claim the AAP has repeatedly denied.

Expert Perspectives and Public Health Implications

Independent health experts have expressed alarm over the precedent set by terminating established grants mid-cycle based on linguistic or ideological disagreements.

“Federal grants are typically awarded based on a rigorous, peer-reviewed process designed to identify the most effective ways to save lives,” says Sarah Thompson, MD, a public health researcher not affiliated with the AAP. “When funding for SIDS prevention or autism screening is pulled overnight, we don’t just lose data; we lose the infrastructure that helps parents and doctors catch problems before they become crises.”

Dr. Thompson noted that racial and ethnic disparities in infant mortality are well-documented in medical literature. “Addressing these disparities isn’t ‘identity politics’; it’s fundamental epidemiology. If we ignore where the greatest risks lie, we cannot effectively improve public health outcomes.”

Looking Ahead

The AAP has received approximately $18.4 million in federal funding throughout 2025. While it is unclear exactly how much of that total remains after this week’s cancellations, the loss of these millions is expected to halt several national outreach campaigns immediately.

As the legal battle between the AAP and HHS moves through the federal court system, the immediate concern for many providers is the “care gap” left behind. Without federal support for these specific AAP programs, state and local health departments may be forced to pick up the slack, though many are already facing their own budget constraints following a separate $11.4 billion clawback of supplemental pandemic funding earlier this year.

For parents and caregivers, the practical implication is a potential reduction in available resources for specialized screenings and educational materials. Pediatricians are encouraging families to continue following the AAP’s evidence-based clinical guidelines, regardless of the funding status of the organization’s outreach arms.

Medical Disclaimer

This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.